Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Harvard Business School
McKesson
AstraZeneca
Farmers Insurance
Covington
US Army
Daiichi Sankyo
Argus Health

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,791,097

« Back to Dashboard

Which drugs does patent 8,791,097 protect, and when does it expire?

Patent 8,791,097 protects TORISEL and is included in one NDA.

Protection for TORISEL has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has thirty-two patent family members in twenty-three countries.
Summary for Patent: 8,791,097
Title:Anti-tumor activity of CCI-779 in papillary renal cell cancer
Abstract: This invention provides the method or use of CCI-779 in the treatment of papillary renal cell carcinoma.
Inventor(s): Dukart; Gary (Ambler, PA), Gibbons, Jr.; James Joseph (Westwood, NJ), Berkenblit; Anna (Needham, MA), Feingold; Jay Marshall (Wynnewood, PA)
Assignee: Wyeth LLC (New York, NY)
Application Number:12/099,394
Patent Claim Types:
see list of patent claims
Use; Delivery;

Drugs Protected by US Patent 8,791,097

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Pf Prism Cv TORISEL temsirolimus SOLUTION;INTRAVENOUS 022088-001 May 30, 2007 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 8,791,097

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2008236621 ➤ Try a Free Trial
Brazil PI0809322 ➤ Try a Free Trial
Canada 2681451 ➤ Try a Free Trial
Chile 2008001009 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
US Department of Justice
Daiichi Sankyo
Johnson and Johnson
Moodys
Chubb
Cerilliant
Cantor Fitzgerald
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.